IP Verse

Curevac patent opposition analysis

Get complete Patent Opposition Report for Curevac

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Latest patents of Curevac opposed by its competitors

Explore Curevac's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent Number	Grant Date	Title	Total Oppositions
EP3283059	Jan 3, 2024	Method For Producing Rna Compositions	21
EP4155409	Dec 27, 2023	Method Of Increasing The Replication Of A Circular Dna Molecule	8
EP4108769	Aug 30, 2023	A Method For Producing And Purifying Rna, Comprising At Least One Step Of Tangential Flow Filtration	10
EP4023755	Apr 26, 2023	Artificial Nucleic Acid Molecules For Improved Protein Expression	8
EP3521456	Jan 4, 2023	Methods And Means For Enhancing Rna Production	9
EP3708668	Jul 27, 2022	Artificial Nucleic Acid Molecules For Improved Protein Expression	8
EP3283125	Dec 29, 2021	Lyophilization Of Rna	6
EP3115064	Nov 24, 2021	Rna-Coded Antibody	2
EP2680880	Nov 10, 2021	Vaccination In Newborns And Infants	2
EP3297682	Jul 14, 2021	Dry Powder Composition Comprising Long-Chain Rna	4

Top competitors of Curevac

BIONTECH

SANOFI

STRAWMAN